Trip or No Trip? The Diverging Development of Psychedelic Drugs for Mental Health (Subscription required) Adrienne Rivlin Read more
Video / Webinar Biotech and Pharmaceuticals Pharma's Big Shift: From Doctors to Payers Providers and Patients July 25, 2024
Case Study Biotech and Pharmaceuticals Reimbursement Assessment for a Therapy for Hemodialysis Patients May 3, 2024 A biopharmaceutical company with a novel treatment of chronic kidney disease-associated pruritus asked L.E.K. to assess the potential risk of bundling of…
Executive Insights Diagnostics, Tools and Personalized Medicine Autologous Cell Therapy: Key Challenges and Bioprocessing Innovations February 7, 2024
Executive Insights Life Sciences & Pharma The Inflation Reduction Act: Implications for Drug Delivery Innovation January 3, 2024
Podcast Life Sciences & Pharma Access, Efficacy and Collaboration: Unlocking the Potential of Gene Therapies September 13, 2023